Comparative studies on in vitro methods for evaluating in vivo function of MDR1 P-glycoprotein

被引:173
作者
Adachi, Y [1 ]
Suzuki, H [1 ]
Sugiyama, Y [1 ]
机构
[1] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan
关键词
MDR1; P-glycoprotein; blood-brain barrier; transcellular transport; ATP-hydrolysis; mdr1 knockout mice;
D O I
10.1023/A:1013358126640
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. MDR1 P-glycoprotein (P-gp) plays an important role in determining drug disposition. The purpose of the present study was to establish in vitro models to predict the in vivo function of P-gp. Methods. As an in vitro method, the transcellular transport of 12 compounds across the monolayer of Caco-2- and MDR1-transfected cells was examined. The ability of these compounds to stimulate the ATP hydrolysis was also determined using the isolated membrane fraction expressing P-gp. As a parameter to describe the in vivo P-gp function, we calculated the brain-to-plasma concentration ratio of compounds in mdr1a/1b knockout mice divided by the same ratio in wild type mice. Results. A good correlation was observed between the in vitro flux ratio across the monolayer and in vivo P-gp function for 12 compounds. Although all compounds that stimulated ATP hydrolysis were significantly transported by P-gp, some compounds were transported by P-gp without significantly affecting ATP hydrolysis. Conclusion. Collectively, the in vitro flux ratio across monolayers of P-gp-expressing cells may be used to predict in vivo P-gp function. The extent of ATP-hydrolysis in vitro may also be a useful parameter for in vivo prediction, particularly for eliminating P-gp substrates in high-throughput screening procedures.
引用
收藏
页码:1660 / 1668
页数:9
相关论文
共 31 条
[1]   Biochemical, cellular, and pharmacological aspects of the multidrug transporter [J].
Ambudkar, SV ;
Dey, S ;
Hrycyna, CA ;
Ramachandra, M ;
Pastan, I ;
Gottesman, MM .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1999, 39 :361-398
[2]   Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery [J].
Benet, LZ ;
Izumi, T ;
Zhang, YC ;
Silverman, JA ;
Wacher, VJ .
JOURNAL OF CONTROLLED RELEASE, 1999, 62 (1-2) :25-31
[3]   Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophore as revealed by its ATPase activity [J].
Borgnia, MJ ;
Eytan, GD ;
Assaraf, YG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (06) :3163-3171
[4]   Co-operative binding sites for transported substrates in the multiple drug resistance transporter Mdr1 [J].
Buxbaum, E .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 265 (01) :64-70
[5]   INTERNAL DUPLICATION AND HOMOLOGY WITH BACTERIAL TRANSPORT PROTEINS IN THE MDR1 (P-GLYCOPROTEIN) GENE FROM MULTIDRUG-RESISTANT HUMAN-CELLS [J].
CHEN, CJ ;
CHIN, JE ;
UEDA, K ;
CLARK, DP ;
PASTAN, I ;
GOTTESMAN, MM ;
RONINSON, IB .
CELL, 1986, 47 (03) :381-389
[6]   POTENTIATION OF ANTICANCER-DRUG CYTOTOXICITY BY MULTIDRUG-RESISTANCE CHEMOSENSITIZERS INVOLVES ALTERATIONS IN MEMBRANE FLUIDITY LEADING TO INCREASED MEMBRANE-PERMEABILITY [J].
DRORI, S ;
EYTAN, GD ;
ASSARAF, YG .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1995, 228 (03) :1020-1029
[7]   6′,7′-Dihydroxybergamottin in grapefruit juice and Seville orange juice:: Effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein [J].
Edwards, DJ ;
Fitzsimmons, ME ;
Schuetz, EG ;
Yasuda, K ;
Ducharme, MP ;
Warbasse, LH ;
Woster, PM ;
Schuetz, JD ;
Watkins, P .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (03) :237-244
[8]   Complete in vivo reversal of P-glycoprotein pump function in the blood-brain barrier visualized with positron emission tomography [J].
Hendrikse, NH ;
Schinkel, AH ;
De Vries, EGE ;
Fluks, E ;
Van der Graaf, WTA ;
Willemsen, ATM ;
Vaalburg, W ;
Franssen, EJF .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 (07) :1413-1418
[9]   Functional polymorphisms of the human multidrug-resistance gene:: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo [J].
Hoffmeyer, S ;
Burk, O ;
von Richter, O ;
Arnold, HP ;
Brockmöller, J ;
Johne, A ;
Cascorbi, I ;
Gerloff, T ;
Roots, I ;
Eichelbaum, M ;
Brinkmann, U .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) :3473-3478
[10]   Role of blood-brain barrier P-glycoprotein in limiting brain accumulation and sedative side-effects of asimadoline, a peripherally acting analgaesic drug [J].
Jonker, JW ;
Wagenaar, E ;
van Deemter, L ;
Gottschlich, R ;
Bender, HM ;
Dasenbrock, J ;
Schinkel, AH .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 127 (01) :43-50